Volume 32, Number 11—November 2026
Research
Invasive Enterovirus and Parechovirus Infections in Adults, Alberta, Canada, 2023–2025
Jamil N. Kanji
, Hong Yuan Zhou, Nathan Zelyas, Kanti Pabbaraju, Anita Wong, Kara Gill, Tarah Lynch, Graham Tipples, Nabeela Nathoo, Dima Kabbani, and Adil Adatia
, Hong Yuan Zhou, Nathan Zelyas, Kanti Pabbaraju, Anita Wong, Kara Gill, Tarah Lynch, Graham Tipples, Nabeela Nathoo, Dima Kabbani, and Adil Adatia
Table 1
Numbers of specimens tested for enterovirus and parechovirus from adults with invasive infections, Alberta, Canada, 2023–2025
| Specimens | No. (%) specimens/study year |
Total, no. (%) | ||
|---|---|---|---|---|
| 2023 | 2024 | 2025 | ||
| No. specimens received* |
3,723 |
5,767 |
6,131 |
15,621 |
| Positive for virus |
42 (1.1) |
58 (1.0) |
62 (1.0) |
162 (1.0) |
| Positive invasive infection† | 15 (35.7) | 9 (15.5) | 27 (43.5) | 51 (31.5) |
| Cerebrospinal fluid samples | 15 (100) | 8 (88.9) | 17 (63.0) | 40 (78.4) |
| Blood samples | 0 | 1 (11.1) | 7 (25.9) | 8 (15.7) |
| Sterile tissue samples | 0 | 0 | 3 (11.1) | 3 (5.9) |
*All specimens received (sterile and nonsterile sites). †No. (%) virus-positive samples. Counts reflect positive specimens; some patients contributed >1 specimen.
Page created: September 14, 2026
Page updated: October 22, 2026
Page reviewed: October 22, 2026
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.